These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25420502)

  • 1. Implantation of a biventricular defibrillator in a borderline case of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Coppola G; Quagliana A; Ciaramitaro G; Corrado E; Inciardi R; Rotolo A; Evola S; Farinella M; Novo G; Assennato P
    Minerva Cardioangiol; 2014 Dec; 62(6):497-9. PubMed ID: 25420502
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
    Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmogenic right ventricular dysplasia and the implantable cardioverter-defibrillator: a case report and review of the literature.
    Cohen TJ; Zadeh H; Fruauff A; Klein J
    J Invasive Cardiol; 2000 Aug; 12(8):422-4. PubMed ID: 10953107
    [No Abstract]   [Full Text] [Related]  

  • 4. Subcutaneous Implantable Cardioverter-Defibrillator and Arrhythmogenic Right Ventricular Cardiomyopathy: The Importance of Repeat ECG Screening During Exercise Test.
    Migliore F; Bertaglia E; Zorzi A; Corrado D
    JACC Clin Electrophysiol; 2017 Jul; 3(7):785-786. PubMed ID: 29759546
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of a coronary sinus lead and biventricular ICD to correct a sensing abnormality in a patient with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Bilchick KC; Judge DP; Calkins H; Marine JE
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):317-20. PubMed ID: 16643408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A particular malignant case of untreatable ventricular arrhythmias in arrhythmogenic cardiomyopathy.
    Molina-Martin de Nicolas J; Fontenla Cerezuela A; Diaz Anton B; Rubio Alonso B; Salgado Aranda R; Salguero Bodes R; Lopez Gil M; Arribas Ynsaurriaga F
    Int J Cardiol; 2015 Mar; 182():307-8. PubMed ID: 25585375
    [No Abstract]   [Full Text] [Related]  

  • 7. Inappropriate mode switching in a dual-chamber defibrillator system: what is the mechanism?
    Williams ES; Knapp MI; Patton KK
    Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):e67-8. PubMed ID: 22715242
    [No Abstract]   [Full Text] [Related]  

  • 8. Left ventricular sensing and pacing for sensing difficulties in internal cardioverter defibrillator therapy for arrhythmogenic right ventricular cardiomyopathy.
    Lochy S; François B; Hollanders G; Provenier F
    Europace; 2010 Aug; 12(8):1195-6. PubMed ID: 20348554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
    Schinkel AF
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of arrhythmogenic right ventricular cardiomyopathy with biventricular involvement.
    Brandimarte F; Battagliese A; Pirillo SP; Mallus MT; Manfredi RM; Carreras G
    Monaldi Arch Chest Dis; 2019 Mar; 89(1):. PubMed ID: 30968669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic right ventricular cardiomyopathy.
    Pike R
    Can J Cardiovasc Nurs; 2009; 19(2):5-9. PubMed ID: 19517899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H
    J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From chest pain to cardioverter-defibrillator implantation--a case report].
    Lewandowski A; Kostarska-Srokosz E; Grzywanowska-Łaniewska I; Moszczeński M; Dłuzniewski M
    Kardiol Pol; 2007 Oct; 65(10):1231-4; discussion 1234. PubMed ID: 17979053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of sudden cardiac deaths in arrhythmogenic right ventricular cardiomyopathy: how to evaluate risk and when to implant a cardioverter-defibrillator?
    Woźniak O; Włodarska EK
    Cardiol J; 2009; 16(6):588-91. PubMed ID: 19950101
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy.
    Inciardi RM; Rotolo A; Coppola G; Clemenza F; Giordano U; Lombardo E; Schicchi R; Torcivia R; Arrotti S; Leggio G; Novo S; Assennato P
    Int J Cardiol; 2014 Apr; 172(3):e468-9. PubMed ID: 24485618
    [No Abstract]   [Full Text] [Related]  

  • 16. Left ventricular pacing in right ventricular cardiomyopathy: blessing or blunder?
    Niazi I; Rennick N; Kiemen JA; Sra J
    Pacing Clin Electrophysiol; 2013 Mar; 36(3):e64-6. PubMed ID: 21895726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making?
    Wichter T; Breithardt G
    J Am Coll Cardiol; 2005 Feb; 45(3):409-11. PubMed ID: 15680720
    [No Abstract]   [Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
    J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of antitachycardia pacing in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Ruiz-Salas A; Barrera-Cordero A; Viñolas X; Sola NB; Álvarez LP; Olalla JJ; Brugada J; Alzueta J
    Int J Cardiol; 2015 Feb; 181():172-3. PubMed ID: 25528304
    [No Abstract]   [Full Text] [Related]  

  • 20. Inappropriate shocks by subcutaneous defibrillator in a patient with arrhythmogenic right ventricular cardiomyopathy: problem fixed.
    Allocca G; Sitta N; Turiano G
    Europace; 2015 Jul; 17(7):1067. PubMed ID: 25842275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.